News About: Pharm. Industry
Hyundai Pharm’s paroxetine CR debuts in antidepression market
Hyundai Pharm has released an oral controlled release type of antidepressant paroxetine as part of efforts to expand its product line-up.
Paroxetine CR is indicated for treatment of depression, panic disorder, soci...
Deccan Value Advisors makes M&A bid for Whanin Pharm
Deccan Value Advisors, the second largest shareholder of Whanin Pharm, made a merger and acquisition (M&A) bid for the company but without success.
In the general shareholders meeting on March 20, the foreign capit...
Samjin succeeds in formulating clopidogrel in globule form
Samjin Pharm announced it has started synthesizing clopidogrel bisulfate (hydrogen sulfate) in globulet form after the recent approval of the Ministry of Health, Welfare and Family Affairs.
The company is expected ...
Rebate provision is still rampant
Rebates are rampant in the medical world where drug makers support or finance seminars, golf tours or other events in return for the promotion of their products.
Most of leading pharmaceutical companies have offere...
Daewoong to release new package form of Ursa for young women
Daewoong Pharm plans to market a new package form “Alpha Ursa” for female customers next month.
The product will appeal to many young women who experience skin trouble as the company aims to publicize the prophylac...
Two Boryung executives win prize at Korea Commerce & Industry Day
Boryung Pharm said that managing director Kim Ji-whan and director Lee Moon-sun won the Knowledge Economy Minister's prize at the 36th Korea Commerce & Industry Day for recognition of their contribution to promoting t...
Korea Prime Pharm to get 2 billion investment
The Korea Development Bank said it has invested 2.0 billion won in Korea Prime Pharm in a form of capital investment, following the investment decision of Korea Credit Guarantee Fund last December
Both sides signed...
Binex eyes Vietnamese market
Binex is exploring overseas market to boost sales of its own cell therapeutics.
The company signed a memorandum of understanding with a local hospital in Vietnam to supply its cell therapeutics there.
Binex is a...
New drugs essential to sustained company growth
Domestic drug makers should focus on research and development of new drugs to survive in business slump, experts said.
Such research-oriented pharmaceutical firms as Dong-A, Bukwang, Yuhan and Yuyu marketed relativ...
Korean drugmakers eye growth through OTC products
With the government’s plan to allow supermarkets to sell OTC products in the near future, Korean pharmaceutical firms set about shaking up their existing organizations and paving the way for its future.
They aim to...
